Pembrolizumab plus lenvatinib in the treatment of unresectable cutaneous angiosarcoma: a study protocol of multicentre, open-label phase II study (NCCH2213, PLAS).

Authors

Dai Ogata, Eiji Nakano, Naoya Yamazaki, Takeru Funakoshi, Akira Takahashi, Ayano Maruyama, Motoki Nakamura, Ryunosuke Machida, Yukari Nagasaka, Kanako Kagatsume, Masako Inaba, Takako Hitomi, Kenjiro Namikawa

Published in

BMJ open. Volume 16. Issue 10. Pages e120316. Oct 09, 2026. Epub Oct 09, 2026.

PMID:
42855246
Bibliographic data and abstract were imported from PubMed on 10 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.